Expression of laminin in pancreatic neoplasms and in chronic pancreatitis.
The distribution of laminin, a basement membrane glycoprotein, was studied by immunohistological techniques in 10 samples of normal pancreatic tissue, in 15 samples of chronic pancreatitis, and in 33 pancreatic neoplasms. Sections of formalin-fixed, paraffin-embedded specimens were pretreated with pepsin and immunostained for laminin. As judged by the expression of laminin, normal pancreatic glands were surrounded by a continuous, intact basement membrane. In chronic pancreatitis the basement membrane was also mainly continuous, but focally weaker and thinner than around normal glands. In pancreatic adenocarcinomas laminin was irregularly distributed and in large areas totally absent. In anaplastic carcinomas no extracellular laminin was seen, but two cases showed some intracellular laminin in a punctate pattern. The findings suggest that these cancers have defects in the deposition of a basement membrane or that it is degraded. Our data suggest that the integrity of the basement membrane correlates with the degree of malignancy in ductal adenocarcinomas, but this is not the case for mucinous cystic neoplasms or for islet cell tumors. In these neoplasms a nearly intact basement membrane was seen both in malignant tumors and in their benign counterparts.
D000230:Adenocarcinoma / Q000032:analysis*; D007516:Adenoma, Islet Cell / Q000032:analysis; D001485:Basement Membrane / Q000473:pathology; D002277:Carcinoma / Q000032:analysis; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000032:analysis; D002908:Chronic Disease; D003536:Cystadenocarcinoma / Q000032:analysis; D003537:Cystadenoma / Q000032:analysis; D003937:Diagnosis, Differential; D006801:Humans; D007797:Laminin / Q000032:analysis*; D010190:Pancreatic Neoplasms / Q000032:analysis*; D010195:Pancreatitis / Q000378:metabolism* / Q000473:pathology
D007797:Laminin